The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Non-Opioid Pain Treatment Market Research Report 2024

Global Non-Opioid Pain Treatment Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1716001

No of Pages : 85

Ask Your Query

Synopsis

Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals.

The global Non-Opioid Pain Treatment market was valued at US$ 19550 million in 2023 and is anticipated to reach US$ 56280 million by 2030, witnessing a CAGR of 16.0% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Non-Opioid Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Opioid Pain Treatment.

Report Scope

The Non-Opioid Pain Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Opioid Pain Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-Opioid Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Allergan PLC
  • Canopy Growth
  • Medical Marijuana Inc.
  • Panag Pharma Inc.
  • Tilray
  • Aphria Inc.
  • Bedrocan
  • Cara Therapeutics
  • Centrexion Therapeutics
  • CHT Medical
  • Cronos Group
  • GW Pharmaceuticals
  • Medropharm Gmbh
  • US Worldmeds LLC

Segment by Type

  • Medical Cannabis Treatment
  • Capsaicin-derived Treatment
  • Menthol-containing Treatment
  • Omega 3 fatty acid-containing Treatment
  • Botulinum Toxins

Segment by Application

  • Orthopaedic and Musculoskeletal Pain
  • Neuropathic Pain
  • Cancer Pain
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Opioid Pain Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medical Cannabis Treatment
1.2.3 Capsaicin-derived Treatment
1.2.4 Menthol-containing Treatment
1.2.5 Omega 3 fatty acid-containing Treatment
1.2.6 Botulinum Toxins
1.3 Market by Application
1.3.1 Global Non-Opioid Pain Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Orthopaedic and Musculoskeletal Pain
1.3.3 Neuropathic Pain
1.3.4 Cancer Pain
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Opioid Pain Treatment Market Perspective (2019-2030)
2.2 Non-Opioid Pain Treatment Growth Trends by Region
2.2.1 Global Non-Opioid Pain Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Non-Opioid Pain Treatment Historic Market Size by Region (2019-2024)
2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Region (2025-2030)
2.3 Non-Opioid Pain Treatment Market Dynamics
2.3.1 Non-Opioid Pain Treatment Industry Trends
2.3.2 Non-Opioid Pain Treatment Market Drivers
2.3.3 Non-Opioid Pain Treatment Market Challenges
2.3.4 Non-Opioid Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Opioid Pain Treatment Players by Revenue
3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2019-2024)
3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Opioid Pain Treatment Revenue
3.4 Global Non-Opioid Pain Treatment Market Concentration Ratio
3.4.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2023
3.5 Non-Opioid Pain Treatment Key Players Head office and Area Served
3.6 Key Players Non-Opioid Pain Treatment Product Solution and Service
3.7 Date of Enter into Non-Opioid Pain Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Opioid Pain Treatment Breakdown Data by Type
4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2019-2024)
4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2025-2030)
5 Non-Opioid Pain Treatment Breakdown Data by Application
5.1 Global Non-Opioid Pain Treatment Historic Market Size by Application (2019-2024)
5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Non-Opioid Pain Treatment Market Size (2019-2030)
6.2 North America Non-Opioid Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Non-Opioid Pain Treatment Market Size by Country (2019-2024)
6.4 North America Non-Opioid Pain Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Opioid Pain Treatment Market Size (2019-2030)
7.2 Europe Non-Opioid Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Non-Opioid Pain Treatment Market Size by Country (2019-2024)
7.4 Europe Non-Opioid Pain Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Opioid Pain Treatment Market Size (2019-2030)
8.2 Asia-Pacific Non-Opioid Pain Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Opioid Pain Treatment Market Size (2019-2030)
9.2 Latin America Non-Opioid Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Non-Opioid Pain Treatment Market Size by Country (2019-2024)
9.4 Latin America Non-Opioid Pain Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Opioid Pain Treatment Market Size (2019-2030)
10.2 Middle East & Africa Non-Opioid Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan PLC
11.1.1 Allergan PLC Company Detail
11.1.2 Allergan PLC Business Overview
11.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction
11.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.1.5 Allergan PLC Recent Development
11.2 Canopy Growth
11.2.1 Canopy Growth Company Detail
11.2.2 Canopy Growth Business Overview
11.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction
11.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.2.5 Canopy Growth Recent Development
11.3 Medical Marijuana Inc.
11.3.1 Medical Marijuana Inc. Company Detail
11.3.2 Medical Marijuana Inc. Business Overview
11.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction
11.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.3.5 Medical Marijuana Inc. Recent Development
11.4 Panag Pharma Inc.
11.4.1 Panag Pharma Inc. Company Detail
11.4.2 Panag Pharma Inc. Business Overview
11.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction
11.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.4.5 Panag Pharma Inc. Recent Development
11.5 Tilray
11.5.1 Tilray Company Detail
11.5.2 Tilray Business Overview
11.5.3 Tilray Non-Opioid Pain Treatment Introduction
11.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.5.5 Tilray Recent Development
11.6 Aphria Inc.
11.6.1 Aphria Inc. Company Detail
11.6.2 Aphria Inc. Business Overview
11.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction
11.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.6.5 Aphria Inc. Recent Development
11.7 Bedrocan
11.7.1 Bedrocan Company Detail
11.7.2 Bedrocan Business Overview
11.7.3 Bedrocan Non-Opioid Pain Treatment Introduction
11.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.7.5 Bedrocan Recent Development
11.8 Cara Therapeutics
11.8.1 Cara Therapeutics Company Detail
11.8.2 Cara Therapeutics Business Overview
11.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction
11.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.8.5 Cara Therapeutics Recent Development
11.9 Centrexion Therapeutics
11.9.1 Centrexion Therapeutics Company Detail
11.9.2 Centrexion Therapeutics Business Overview
11.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction
11.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.9.5 Centrexion Therapeutics Recent Development
11.10 CHT Medical
11.10.1 CHT Medical Company Detail
11.10.2 CHT Medical Business Overview
11.10.3 CHT Medical Non-Opioid Pain Treatment Introduction
11.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.10.5 CHT Medical Recent Development
11.11 Cronos Group
11.11.1 Cronos Group Company Detail
11.11.2 Cronos Group Business Overview
11.11.3 Cronos Group Non-Opioid Pain Treatment Introduction
11.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.11.5 Cronos Group Recent Development
11.12 GW Pharmaceuticals
11.12.1 GW Pharmaceuticals Company Detail
11.12.2 GW Pharmaceuticals Business Overview
11.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction
11.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.12.5 GW Pharmaceuticals Recent Development
11.13 Medropharm Gmbh
11.13.1 Medropharm Gmbh Company Detail
11.13.2 Medropharm Gmbh Business Overview
11.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction
11.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.13.5 Medropharm Gmbh Recent Development
11.14 US Worldmeds LLC
11.14.1 US Worldmeds LLC Company Detail
11.14.2 US Worldmeds LLC Business Overview
11.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction
11.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2019-2024)
11.14.5 US Worldmeds LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock